Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tulmimetostat and Pembrolizumab in Advanced Non-small Cell Lung Cancer
NCT05467748Phase 2Recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Dec 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tulmimetostat in non-small cell lung cancer (NSCLC), sponsored by VA Office of Research & Development. Started Dec 2025; status: recruiting.
02
Drugs
tulmimetostat
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT05467748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05467748.